DiShi Medical
迪视医疗
DiShi Medical (迪视医疗, also known as DigiSight Medical) is a Hangzhou-based microsurgical robotics platform founded in July 2021, specializing in ophthalmic and ultra-microsurgical intelligent robotic systems . The company was founded by CEO Cui Di, whose team draws from top German robotics and AI labs and Fortune 500 pharmaceutical firms . Its flagship product, the "DiShi Weifeng" (迪视微锋) ophthalmic surgical robot, is positioned as one of the highest-precision systems globally and completed Asia's first clinical application of ophthalmic robotics in 2023 . The company's clinical focus addresses a shortage of fundus surgeons, aims to extend physicians' careers, and intends to serve as a delivery tool for gene and cell therapies . DiShi Medical raised tens of millions of RMB in a Pre-A round led by Linear Capital with follow-on from GL Ventures (高瓴创投) in early 2023, with proceeds directed toward NMPA Class III medical device registration and pipeline R&D . Linear Capital has featured the company as part of its portfolio of European university-linked technical founders .
AI-generated — may contain errors, please verify.
Coverage
Spring has arrived — can blossoms be far behind? | Linear Quarterly
Rather than waiting for spring, define it.
Linear Voice: 2025 in the Linear Capital Network
Those real and important moments.
Before the Start of Winter, Building Inner Strength | Linear Quarterly
Fearless through the winter, growing inward.
The First Newsletter of Autumn | Linear Quarterly
Cycles turn, and Wanwu Capital begins to harvest.
"Digisight Medical" Closes Nearly 100 Million RMB Series A, Leading Microsurgical Robotics | Linear Portfolio
Accelerating clinical application and market expansion.
Taking Gems From Fire — Linear Capital's 2024 Year in Review
2024 is coming to a close. I'd like to borrow the theme from our annual meeting in October to summarize this year: *Taking Gems From Fire* — a fitting description of Linear Capital's work this past year.
Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier tech and innovation fund.
Linear Capital Partner Songyan Huang Makes Repeat Appearance on 36Kr's "36 Under 36" Investors List
Recently, 36Kr released its 2024 ["36under36" series rankings](https://mp.weixin.qq.com/s?__biz=Mzk0MDMyNDUxOQ==&mid=2247490968&idx=1&sn=027309e5c24b1eceda88d9ae5095a639&scene=21&
Linear Capital Partner Songyan Huang Retains Spot on Cyzone's "Under 40 Investors" List
This week, ChinaBang (创业邦) released its 2024 "Top Investors Under 40" list, evaluating nominees across three dimensions: **overall influence, investment performance, and exit performance**. Among the honorees, Linear Capital partner Songyan Huang made the list for the third consecutive year, following his selections in [2022](http://mp.weixin.qq.com/s?__biz=MzAwNTAyMDAyNQ==&mid=2652302
At ICRA 2024, Linear Capital and several of its portfolio robotics teams from China, Germany, and Switzerland look forward to meeting you!
ICRA, the IEEE International Conference on Robotics and Automation, is the largest and most influential academic conference in robotics. From May 13 to May 17, 2024, ICRA 2024 will be held in Yokohama, Japan. Linear Capital will attend with its portfolio companies Horizon Robotics, Agile Robots, and F
Linear Capital's Eindhoven offline networking event — sign up now!
**In late April, Linear Capital's investment team will host an offline entrepreneur meetup in Eindhoven to share the latest updates and insights on China's hard tech investment scene. Harry Wang, founder and CEO of Linear Capital, along with partner Songyan Huang and senior director Xin Wei, will attend the event.** Entrepreneurs, PhD candidates, and postdoctoral researchers are welcome to sign up — whether you're looking to commercialize a research project, have a startup idea, or are simply curious about...
Linear Capital Leuven Offline Exchange Event — Now Open for Registration!
**In late April, Linear Capital's investment team will host an offline entrepreneurship meetup in Leuven, sharing the latest insights and updates on China's hard tech investment landscape. Harry Wang, founder and CEO of Linear Capital, partner Songyan Huang, and senior director Xin Wei will attend the event.** Entrepreneurs, PhD candidates, and postdoctoral researchers are welcome to sign up — whether you're looking to commercialize a research project, exploring a startup idea, or simply curious about the domestic [Chinese] market.
Zhejiang University alumni in Zurich — heads up! Linear Capital vs. Zhejiang University Alumni Association Zurich: April meetup now open for registration!
Last spring, Linear Capital traveled to Europe to visit top universities, tour three major robotics labs, and other key innovation platforms. We got a firsthand feel for the research and frontier technology in developed countries like the UK, France, and Germany, and also had extensive conversations and preliminary discussions with local student organizations and entrepreneurs. In 2024, we'll be expanding our engagement with university groups and alumni networks across Europe through a broader range of formats and partnerships.
Explore Frontier Tech — Linear Capital's April Delft Offline Meetup Awaits
Last spring, Linear Capital traveled to Europe to visit top universities, tour three major robotics labs, and other key innovation hubs. The team got firsthand exposure to cutting-edge research and technology across the UK, France, Germany, the Netherlands, and Switzerland, and also held extensive discussions and preliminary exchanges with local student organizations and entrepreneurs.
Join us in Aachen for frontier tech discussions — Linear Capital's April offline meetup is now open for registration!
**In late April, Linear Capital's investment team will co-host an offline entrepreneurship exchange with the Aachen Chinese Students and Scholars Association, sharing the latest updates and insights on domestic hard-tech investing. Harry Wang, founder and CEO of Linear Capital, partner Songyan Huang, and senior director Xin Wei will attend the event.** Entrepreneurs, PhD candidates, postdocs, and other researchers are welcome to sign up — whether you're looking to commercialize a research project, have a startup idea, or simply
ETH Zurich, again — Linear Capital's Switzerland offline event is open for registration!
Last April, Linear Capital's investment team visited several top labs at ETH Zurich and EPFL in Switzerland, and hosted exchange events with local Chinese organizations. The research environment there and the universities' support for early-stage technology commercialization left a deep impression on us. During these events, we also shared with attending technical entrepreneurs Linear Capital's view on the tremendous opportunity of combining cutting-edge European technological innovation with the domestic market. These observations
Event Registration | Linear Capital's April Munich Offline Meetup — You're Invited!
**In mid-April, Linear Capital's investment team will partner with the Munich Chinese Students and Scholars Association to host an in-person meetup in Munich, sharing the latest insights and updates on domestic hard-tech investing. Harry Wang, Founder and CEO of Linear Capital, partner Songyan Huang, and senior director Xin Wei will attend the event.** Doctoral and postdoctoral researchers, as well as technical entrepreneurs, are welcome to sign up — whether you're looking to commercialize a research project or have a startup idea in mind, we'd love to have you join.
"DiSight Medical" Cui Di: Solving Pain Points in Fundus and Microsurgery with High-Precision Ophthalmic Surgical Robots | Linear Capital Portfolio Interview Series
In July 2023, Linear Capital portfolio company Hangzhou Disight Medical Biotechnology Co., Ltd. successfully performed a subretinal thrombolysis procedure for treating macular hemorrhage at Zhejiang Provincial People's Hospital using its "Disight MicroEdge" ophthalmic surgical robot — **the first such procedure in Asia**. The company achieved its clinical milestone just two years after founding, and completed [three rounds of financing](https://mp.weixin.qq.com/s/...) in 2023 alone.
Linear Capital's 2023 Retrospective: Moving Forward Through Challenges
In September 2023, [when summarizing Linear Capital's ninth anniversary, we wrote this line: the goal lies far ahead, the road remains difficult, but there is light in our hearts](https://mp.weixin.qq.com/s?__biz=MzAwNTAyMDAyNQ==&mid=2652305248&idx=1&sn=eb922534db0722f5ef06117e
Unicorns, multiple funding rounds, products already deployed across multiple industries... Ten portfolio robotics companies showcase at Linear Capital's general-purpose intelligent robotics event
Professor Jianwei Zhang, academician of the German National Academy of Science and Engineering and the Hamburg Academy of Sciences and Humanities in Germany, was invited to share his insights.
Red Star Over the West — The Europe Chapter
[Last week](http://mp.weixin.qq.com/s?__biz=MzAwNTAyMDAyNQ==&mid=2652305127&idx=1&sn=a57926357750f1a5edad1ef67de718e0&chksm=80c156f1b7b6dfe710934bfd06d7452e0
Linear Capital Portfolio Company DigiSight Ophthalmic Surgery Robot Completes Asia's First Clinical Application of Ophthalmic Robotics
Recently, portfolio company of Linear Capital **Hangzhou Disight Medical Biotechnology Co., Ltd.** successfully completed its first retinal sub-thrombolysis surgery for treating macular hemorrhage using its **"Disight MicroEdge"** ophthalmic surgical robot at Zhejiang Provincial People's Hospital. The procedure was safe and smooth, the patient recovered well, and has since been discharged in stable condition. This marks the first clinical application of an ophthalmic robot in Asia, representing a major technological advance for the entire field of ophthalmic microsurgery.
Linear Capital's Pre-A lead portfolio company **DigiSight Medical** has closed a multi-million-yuan Pre-A+ round, with existing investor Linear Capital continuing to back the company.
Accelerating clinical trials and R&D for ophthalmic and microsurgical robotic products.
Event Preview | Linear Capital's April Europe Tour Kicks Off — Meet Us IRL If You're Into Frontier Tech!
Europe is one of the world's core regions for technological innovation, and Linear Capital has been closely tracking cutting-edge developments there.
Microsurgical robotics platform "Digisight Medical" raises tens of millions of RMB in Pre-A funding led by Linear Capital | Linear News
Dongli Network has learned that **Dishi Medical recently completed a Pre-A round of financing worth tens of millions of RMB, led by Linear Capital with Hillhouse as a co-investor.** The funds from this round will be used primarily to accelerate NMPA Class III medical device registration for its ophthalmic surgical robot, advance R&D on product lines including microsurgical robots, and expand the team.
